Pathology Named Roche Molecular Center of Excellence | GenomeWeb

NEW YORK (GenomeWeb) – Roche said late on Tuesday that Pathology Inc. has become a Roche Molecular Center of Excellence for the next five years.

With the designation, Pathology's molecular diagnostic laboratory will be able to offer molecular technologies from Roche, such as the US Food and Drug Administration-approved cobas HPV test, to physicians and patients. The test helps clinicians assess a patient's risk of cervical cancer based on the presence of clinically relevant high-risk HPV DNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.